U.S. Army Medical Research & Development Command
The U.S. Army Medical Research & Development Command is a DoD biomedical research organization operating six specialized laboratories and the CDMRP, developing medical countermeasures, devices, and FDA-cleared AI decision-support tools to protect and treat U.S. military warfighters.
- Company typePublic
- Founded1992
- HeadquartersFrederick, United States
- Headcount5,001–10,000
- GTM typeB2B
- OfferingServices
What U.S. Army Medical Research & Development Command does
USAMRDC is the biomedical research command of the U.S. Department of Defense, operating under the Defense Health Agency and headquartered at Fort Detrick, Maryland. It runs six specialized laboratories — USAMRIID, WRAIR, USAMRICD, USAISR, USARIEM, and USAARL — alongside the Congressionally Directed Medical Research Programs (CDMRP), which together cover combat casualty care, infectious diseases (including HIV and malaria countermeasure development), military operational medicine, chemical and biological defense, environmental and thermal medicine, and aeromedical research. Outputs include FDA-cleared decision-support AI tools such as APPRAISE-HRI for hemorrhage resuscitation, FDA-cleared and fielded devices such as the SAM Junctional Tourniquet, immersive training prototypes using mixed-reality headsets, and the HIPAA/HIPPS-type software suites that bridge frontline medics to higher-echelon care.
The command's business model is non-commercial: it is funded entirely through annual congressional appropriations routed via the Defense Health Program and supplemented by Congressionally Directed Medical Research Programs. Its sole primary customer is the U.S. military, with the Department of Defense serving as the anchor buyer and end-user base of military service members. Limited technology-licensing arrangements, such as the partnership with First Line Technology for the Bio-Containment System and SBIR-funded work with commercial vendors like Zeteo Tech, represent the principal pathway by which selected USAMRDC-developed capabilities reach private-sector markets. Strategic direction is set under Commanding General BG Constance L. Jenkins (as of July 2026), with Dr. Carrie M. Quinn serving as deputy and CSM Curtis C. Conklin as senior enlisted advisor.
U.S. Army Medical Research & Development Command firmographics
Firmographics- Name
- U.S. Army Medical Research & Development Command
- Legal name
- U.S. Army Medical Research and Development Command
- Website
- https://mrdc.health.mil
- Company type
- Public
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- The U.S. Army Medical Research & Development Command is a DoD biomedical research organization operating six specialized laboratories and the CDMRP, developing medical countermeasures, devices, and FDA-cleared AI decision-support tools to protect and treat U.S. military warfighters.
- Ownership category
- akta.pro rank
U.S. Army Medical Research & Development Command industry classification
Industry- Product category
- Defense Biomedical Research
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)
- akta.pro secondary industries
- Infectious Disease & Pandemic Preparedness Vaccines (emerging pathogens) (HLAAAEAC), Clinical Research & Trial Central Laboratories (HLAFAMAL)
Keywords
Where U.S. Army Medical Research & Development Command is headquartered
LocationHeadquarters
- HQ city
- Frederick
- HQ country
- United States
- HQ region
- North America
Offices6 records
Markets served
U.S. Army Medical Research & Development Command business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
Revenue model
- Federal Government Appropriations: The command operates as a U.S. Department of Defense organization funded through federal budget appropriations to advance military health and readiness through biomedical research
Distribution channels3 records
Marketing channels6 records
U.S. Army Medical Research & Development Command product offering
Product offeringCore offering
USAMRDC conducts cutting-edge biomedical research through six medical research laboratories (USAMRIID, WRAIR, USAMRICD, USAISR, USARIEM, USAARL) and CDMRP to develop life-saving medical technologies, vaccines, therapeutics, diagnostics, and decision-support tools that protect and sustain the health of U.S. Warfighters across combat casualty care, infectious diseases, chemical/biological defense, environmental medicine, and aeromedical research.
Product overview
DHA R&D-MRDC is a multi-institute biomedical research command that does not offer a single unified product but rather operates a portfolio of specialized research laboratories producing distinct products, technologies, and decision-support tools. The command's subordinate institutes develop targeted medical solutions: USAISR (combat casualty care) produces the SAM Junctional Tourniquet and explores mixed reality for burn care; USAMRIID (infectious diseases) develops vaccines, therapeutics, and the novel antibody discovery platform; USAMRICD (chemical defense) produces bio-scavenger pretreatments and ChemDx diagnostics; USARIEM (environmental medicine) delivers the Heat Injury Prevention Prediction System, Individual Heat Optimization Training Tool, and Cold Weather Ensemble Decision Aid; USAARL (aeromedical research) develops blast exposure monitoring and crashworthy seat technologies. CDMRP serves as a separate research funding mechanism. Key FDA-cleared AI-enabled products include APPRAISE-HRI for hemorrhage triage. The portfolio includes licensed technologies like the Body Cooling System and CAPS hearing protection. The organization emphasizes technology transfer through its Medical Technology Transfer Office to commercialize innovations.
Differentiator
Problem solved
Functional benefit
Products and services
- APPRAISE-HRI (APPRAISE Hemorrhage Risk Indicator) FDA-cleared AI-enabled decision-support software application used by military health care providers to stratify hemorrhage risk of U.S. Service Members after a traumatic event. The first AI software cleared by FDA for hemorrhage triage of combat casualties.
- SAM Junctional Tourniquet Combat casualty care medical device developed by USAISR that addresses bleeding in areas where traditional tourniquets cannot be used, designed for battlefield injuries.
- Heat Injury Prevention Prediction System (HIPPS) Decision-support tool using real-time environmental data and physiological markers to predict heat injury risk before it occurs, allowing commanders to proactively adjust training intensity, hydration, or rest cycles. Currently deployed at Sapper School and the U.S. Marine Corps.
- Individual Heat Optimization Training Tool USARIEM-developed assessment tool that assesses exertional heat illness risk to optimize soldier training in extreme environments and protect health and performance.
- Cold Weather Ensemble Decision Aid USARIEM-developed decision aid that provides guidance on clothing selection for freezing conditions to ensure warfighters can perform effectively in cold environments while minimizing injury risk.
- Body Cooling System (BCS) Heat-exhaustion prevention device consisting of a shallow standing water basin that allows sufferers to submerge hands and forearms to reduce core body temperature. Licensed to First Line Technology, LLC; can increase capacity to work in hot, humid environments by up to 60%.
- Canine Auditory Protection System (CAPS) Hearing protection headgear for military working dogs that blocks unwanted sounds while preserving the animal's ability to hear verbal commands; developed through SBIR partnership with Zeteo Tech, Inc. and University of Cincinnati FETCHLAB.
- Blast Exposure Monitoring Tool USAARL-developed wearable and environmental sensor system that monitors blast exposure and head acceleration impacts, enabling early detection of concussive events during military training and operations.
- ChemDx Field Diagnostic System USAMRICD-developed field diagnostic system for detecting chemical exposure, supporting chemical casualty care and chemical warfare defense operations.
- VISTA Casualty Detection and Assessment Systems TATRC-developed automated casualty detection and assessment system for battlefield medicine, tested at Project Convergence Capstone 5.
- Bio-Scavenger Pretreatments for Nerve Agent Exposure USAMRICD-developed prophylactic pretreatment that provides protection against nerve agent exposure for up to two weeks, enhancing soldier safety in chemical threat environments.
- Rapid Opioid Countermeasure System USAMRICD-developed naloxone auto-injector designed to rapidly treat opioid intoxication in military settings as part of chemical casualty care capabilities.
Quantifiable outcome
- Heat exhaustion prevention device (BCS) can increase capacity to work in hot, humid environments by up to 60%
- +2 more outcomes
Companies that use U.S. Army Medical Research & Development Command
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles2 records
U.S. Army Medical Research & Development Command technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability21 records
Feature10 records
U.S. Army Medical Research & Development Command partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered core.
- First Line Technology, LLCcoreTechnology licensing partnership for the Body Cooling System (BCS) - a shallow standing water basin for hand/forearm immersion cooling to reduce core body temperature. The BCS can increase capacity to work in hot, humid environments by up to 60%. First Line Technology is ISO 9001:2015 certified in disaster preparedness and emergency response equipment.
- Zeteo Tech, Inc.coreSBIR-funded development partner for the Canine Auditory Protection System (CAPS). Zeteo Tech developed the hearing protection headgear for military working dogs in collaboration with USAMRDC, designed to block harmful sounds while maintaining ability to hear commands.
- University of Cincinnati FETCHLABcoreCollaboration with Dr. Pete Scheifele at UC's FETCHLAB (leading animal audiology expert) for development of the Canine Auditory Protection System. Dr. Scheifele identified hearing loss issues in military working dogs and co-developed the solution.
- U.S. Army Research Office (ARO)coreFacilitated initial collaboration between Zeteo Tech and University of Cincinnati researchers, providing Small Business Innovation Research guidance and expertise on military working dog veterinary issues.
- U.S. Army Combat Readiness CentercoreData partnership for USAARL crashworthiness research - analyzing real-world injury patterns and outcomes from helicopter crashes to inform seat design standards.
- U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)coreDirect reporting unit specializing in bio-terror threat mitigation and infectious disease research, developing vaccines, therapeutics, and diagnostics for pathogens including anthrax, Ebola, and Marburg virus.
- Walter Reed Army Institute of Research (WRAIR)coreDoD's largest and most diverse biomedical research institute specializing in infectious diseases, brain health, and Soldier performance optimization. Led development of nearly all FDA-approved antimalarial drugs and world's largest HIV vaccine efficacy trial.
- U.S. Army Institute of Surgical Research (USAISR)coreWorld's leading institute for combat casualty care research, developing life-saving medical innovations for battlefield injuries including the SAM Junctional Tourniquet and burn care advances.
- U.S. Army Medical Research Institute of Chemical Defense (USAMRICD)coreLeading institute for medical chemical defense research, developing bio-scavenger pretreatments for nerve agent exposure and the Rapid Opioid Countermeasure System (naloxone auto-injector).
- U.S. Army Research Institute of Environmental Medicine (USARIEM)coreResearch institute optimizing Soldier health and performance in extreme environments (heat, cold, altitude). Developed the Individual Heat Optimization Training Tool and Cold Weather Ensemble Decision Aid.
- U.S. Army Aeromedical Research Laboratory (USAARL)coreSpecializing in aviation Soldier safety and performance, conducting research on acoustics, vision, blast exposure, and aeromedical devices. Environmental Sensors in Training program monitors blast exposure and head acceleration impacts.
- Defense Health AgencycoreParent organization for DHA R&D-MRDC, overseeing military health system governance and research direction.
- Sapper SchoolcoreOperational deployment of the Heat Injury Prevention Prediction System (HIPPS) for heat injury risk assessment.
- U.S. Marine CorpscoreDeployment of HIPPS heat injury prevention technology and integration into the upcoming Best Medic Competition.
- MITcorePartnership on AI tool development for nerve block anesthetics in collaboration with USAISR.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
U.S. Army Medical Research & Development Command competitors and assessment
Company assessmentBroad incumbents
- RTI International: Independent nonprofit research institute performing health, biomedical, and pharmaceutical research with significant government funding. Comparable scale and scope in conducting government-sponsored life science R&D and clinical research.
- SRI International: Independent nonprofit research institute performing biomedical, pharmaceutical, and defense research for government and commercial clients. Comparable as a multi-disciplinary R&D organization delivering regulated medical products and government-funded science.
- National Institutes of Health (NIH): U.S. government's largest biomedical research funder, with comparable R&D output (vaccines, therapeutics, clinical trials) and similar government-funded model. Comparable in research scope and ability to translate discoveries into clinical products.
- Defense Advanced Research Projects Agency (DARPA): DoD research agency funding high-risk, high-reward technology development including biomedical programs (e.g., battlefield medicine, prosthetics). Sibling organization to USAMRDC within the broader DoD research ecosystem with overlapping aims in defense-relevant medical innovation.
- Battelle Memorial Institute: Large nonprofit applied science R&D organization that manages FFRDCs and conducts biomedical, chemical, and defense research for federal agencies. Operates at a similar scale to USAMRDC in multi-disciplinary government-funded life science and medical research.
- Biomedical Advanced Research Development Authority (BARDA): HHS agency that funds advanced development of medical countermeasures (vaccines, therapeutics, diagnostics) against CBRN threats, pandemic influenza, and emerging infectious diseases. Direct functional overlap with USAMRDC/WRAIR/USAMRIID work on vaccines and pandemic preparedness.
Emerging players
- Charles River Laboratories: Leading CRO providing preclinical research, biologics, and laboratory services to government and biopharma clients. Comparable in life science research services and infectious disease/vaccine testing capabilities relevant to USAMRDC's mission.
- Lovelace Biomedical: Contract research organization specializing in preclinical, inhalation, and infectious disease research with deep government and DoD client relationships. Comparable niche focus on regulated preclinical and CBRN-related biomedical research.
Direct peers
- Naval Medical Research Center (NMRC): U.S. Navy's flagship biomedical research command, operating under Navy Medicine. NMRC conducts infectious disease research, combat casualty care, and operational medicine for Sailors and Marines, making it the closest DoD counterpart to USAMRDC in mission and structure.
- Air Force Research Laboratory - 711th Human Performance Wing: The U.S. Air Force's primary biomedical and human performance research unit, focused on aerospace medicine, operational readiness, and pilot/aircrew health. Highly comparable to USAMRDC in mission (military health R&D) and structure (subordinate labs within a parent command).
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
U.S. Army Medical Research & Development Command social profiles
Digital presenceU.S. Army Medical Research & Development Command financial estimates
Financial estimateRevenue estimate
Valuation estimate
U.S. Army Medical Research & Development Command leadership team
Management profileNumber of profiles
Profiles3 records
U.S. Army Medical Research & Development Command subsidiaries and ownership
Company hierarchySubsidiaries7 records
U.S. Army Medical Research & Development Command funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
U.S. Army Medical Research & Development Command M&A and investment
M&A and investmentM&A
Investments8 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about U.S. Army Medical Research & Development Command
What does U.S. Army Medical Research & Development Command do?
USAMRDC conducts cutting-edge biomedical research through six medical research laboratories (USAMRIID, WRAIR, USAMRICD, USAISR, USARIEM, USAARL) and CDMRP to develop life-saving medical technologies, vaccines, therapeutics, diagnostics, and decision-support tools that protect and sustain the health of U.S. Warfighters across combat casualty care, infectious diseases, chemical/biological defense, environmental medicine, and aeromedical research.
Is U.S. Army Medical Research & Development Command a public or private company?
U.S. Army Medical Research & Development Command is a public company. It is classified as state government owned and is currently operating.
When was U.S. Army Medical Research & Development Command founded?
U.S. Army Medical Research & Development Command was founded in 1992. It employs 5,001 to 10,000 people.
Where is U.S. Army Medical Research & Development Command based?
U.S. Army Medical Research & Development Command is headquartered in Frederick, United States, in the North America region.
How does U.S. Army Medical Research & Development Command make money?
One revenue line is on record: federal Government Appropriations.
Who are U.S. Army Medical Research & Development Command's main competitors?
Broad incumbents on record are RTI International, SRI International, National Institutes of Health (NIH), Defense Advanced Research Projects Agency (DARPA), Battelle Memorial Institute and Biomedical Advanced Research Development Authority (BARDA). Emerging players are Charles River Laboratories and Lovelace Biomedical. Direct peers are Naval Medical Research Center (NMRC) and Air Force Research Laboratory - 711th Human Performance Wing.
Does U.S. Army Medical Research & Development Command have an API?
No public API is recorded for U.S. Army Medical Research & Development Command.
What industry is U.S. Army Medical Research & Development Command in?
U.S. Army Medical Research & Development Command's product category is Defense Biomedical Research. Its primary akta.pro industry code is HLAAAIAB, Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering), with a secondary code of HLAAAEAC, Infectious Disease & Pandemic Preparedness Vaccines (emerging pathogens). Its NAICS code is 5417 and its SIC code is 8731.